Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.43 |
| ▸ | RORC | P51449 | 7/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.34 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21399483 | 0.95 | KIF11 (0.39) | KIF11RORCPTGDR2HSP90AA1L3MBTL1 | |
| SCHEMBL18374149 | 0.94 | KIF11 (0.41) | KIF11RORCPTGDR2 | |
| SCHEMBL19795568 | 0.93 | KIF11 (0.40) | KIF11RORCPTGDR2 | |
| SCHEMBL21399479 | 0.93 | KIF11 (0.39) | KIF11RORCPTGDR2HSP90AA1L3MBTL1 | |
| SCHEMBL21399480 | 0.93 | KIF11 (0.39) | KIF11RORCPTGDR2HSP90AA1L3MBTL1 | |
| SCHEMBL21399688 | 0.93 | KIF11 (0.41) | KIF11PTGDR2HSP90AA1L3MBTL1PDK2 | |
| SCHEMBL24370468 | 0.92 | KIF11 (0.40) | KIF11PTGDR2HSP90AA1 | |
| SCHEMBL19795559 | 0.92 | KIF11 (0.39) | KIF11PTGDR2HSP90AA1L3MBTL1 | |
| SCHEMBL20848913 | 0.91 | KIF11 (0.38) | KIF11RORCPTGDR2 | |
| SCHEMBL21399686 | 0.91 | KIF11 (0.39) | KIF11RORCPTGDR2HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10263196-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2019-04-16 | — | — | US | disclosed |
| EP-3138137-B1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-06-20 | — | — | EP | disclosed |
| US-20180026202-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| WO-2017005699-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2017-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10263196-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, OXER1 | KIF11 4272/4885RORC 2118/4885PTGDR2 2192/4885 |
| US-20180026202-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | ORC3, OR10J3, C1R | KIF11 4250/4885RORC 2231/4885PTGDR2 2025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.